Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV003481895 | SCV004224215 | uncertain significance | not provided | 2022-12-22 | criteria provided, single submitter | clinical testing | BP4 |
Labcorp Genetics |
RCV003779208 | SCV004581039 | uncertain significance | Hereditary spastic paraplegia 8; Ritscher-Schinzel syndrome | 2023-01-14 | criteria provided, single submitter | clinical testing | The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 354 of the WASHC5 protein (p.Met354Val). This variant has not been reported in the literature in individuals affected with WASHC5-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt WASHC5 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |